Steinhart Richard I

CIK 00012937895 companiesNEW HAVEN, CT

SEC Profile

Transactions

Companies

Filings

CIK

0001293789

Recent Transactions

50 trades

Award
BioXcel Therapeutics, Inc.$BTAI
Restricted Stock Units
2026-01-01+70,000→ 70,282 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2025-12-15+35→ 6,577 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Restricted Stock Units
2025-12-15−35→ 282 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2025-12-14+33→ 6,542 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Restricted Stock Units
2025-12-14−33→ 130 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Restricted Stock Units
2025-09-15−35→ 317 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2025-09-15+35→ 6,509 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2025-09-14+33→ 6,474 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Restricted Stock Units
2025-09-14−33→ 163 total
Award
BioXcel Therapeutics, Inc.$BTAI
Restricted Stock Units
2025-08-01+9,000→ 9,000 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Restricted Stock Units
2025-07-22−625→ 0 total
Award
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2025-07-22+4,375→ 5,816 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2025-07-22+625→ 6,441 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Restricted Stock Units
2025-06-15−35→ 352 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2025-06-15+35→ 1,441 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Restricted Stock Units
2025-06-14−33→ 196 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2025-06-14+33→ 1,406 total
Award
ATOSSA THERAPEUTICS, INC.$ATOS
Stock Option (right to buy)
2025-05-15+125,000→ 125,000 total
Disposition to Issuer
Actinium Pharmaceuticals, Inc.$ATNM
Stock Option (Right to Buy)
2025-03-31−2,500→ 0 total
Disposition to Issuer
Actinium Pharmaceuticals, Inc.$ATNM
Stock Option (Right to Buy)
2025-03-31−8,333→ 0 total
Disposition to Issuer
Actinium Pharmaceuticals, Inc.$ATNM
Stock Option (Right to Buy)
2025-03-31−2,500→ 0 total
Disposition to Issuer
Actinium Pharmaceuticals, Inc.$ATNM
Stock Option (Right to Buy)
2025-03-31−18,351→ 0 total
Disposition to Issuer
Actinium Pharmaceuticals, Inc.$ATNM
Stock Option (Right to Buy)
2025-03-31−72,156→ 0 total
Disposition to Issuer
Actinium Pharmaceuticals, Inc.$ATNM
Stock Option (Right to Buy)
2025-03-31−8,333→ 0 total
Disposition to Issuer
Actinium Pharmaceuticals, Inc.$ATNM
Stock Option (Right to Buy)
2025-03-31−2,500→ 0 total
Disposition to Issuer
Actinium Pharmaceuticals, Inc.$ATNM
Stock Option (Right to Buy)
2025-03-31−70,311→ 0 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Restricted Stock Units
2025-03-15−34→ 387 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2025-03-15+34→ 1,373 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2025-03-14+31→ 1,339 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Restricted Stock Units
2025-03-14−31→ 229 total
Award
BioXcel Therapeutics, Inc.$BTAI
Stock Option (right to buy)
2025-01-07+270,000→ 270,000 total
Sale
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2024-12-16$0.36/sh−372→ 20,932 total
Sale
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2024-12-16$0.36/sh−205→ 21,157 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Restricted Stock Units
2024-12-15−562→ 5,064 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2024-12-15+562→ 21,362 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Restricted Stock Units
2024-12-14−521→ 2,606 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2024-12-14+521→ 20,800 total
Sale
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2024-10-03$0.55/sh−7,175→ 20,279 total
Award
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2024-09-17+21,250→ 27,454 total
Sale
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2024-09-16$0.69/sh−356→ 6,204 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Restricted Stock Units
2024-09-15−563→ 5,625 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2024-09-15+563→ 6,560 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Restricted Stock Units
2024-09-14−521→ 3,127 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2024-09-14+521→ 5,997 total
Award
BioXcel Therapeutics, Inc.$BTAI
Restricted Stock Units
2024-07-22+625→ 625 total
Award
BioXcel Therapeutics, Inc.$BTAI
Stock Option (right to buy)
2024-07-22+1,875→ 1,875 total
Award
ATOSSA THERAPEUTICS, INC.$ATOS
Stock Option (right to buy)
2024-06-27+125,000→ 125,000 total
Sale
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2024-06-17$1.26/sh−372→ 5,476 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Restricted Stock Units
2024-06-15−562→ 6,188 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2024-06-15+562→ 5,848 total

Companies

Recent Filings

Address

C/O BIOXCEL THERAPEUTICS, INC. 555 LONG WHARF DRIVE, 12TH FLOOR

NEW HAVEN, CT, 06511

View on SEC.gov